menu search

Precision biosciences: a watch list stock going into ash presentation

Precision BioSciences has been on the candidate list for my Compounding Healthcare “Bio Boom” Portf...

December 6, 2022, 4:34 am

Silence therapeutics: excellent data in a cardiovascular indication

SLN is a gene silencing therapy developer. SLN produced excellent data from its lead candidate....

December 6, 2022, 2:19 am

Gsk's myelofibrosis candidate maa gets accepted in europe

GSK's new drug application (NDA) for momelotinib is under standard FDA review, with a decision expected on Jun 16, 2023....

December 5, 2022, 12:02 pm

Hillevax announces positive immunogenicity results for run-in cohort of nest-in1 phase 2b clinical trial of hil-214 norovirus vaccine candidate

BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerc...

December 5, 2022, 11:30 am

Algernon pharmaceuticals says ifenprodil granted orphan drug designation by us fda for treatment of ipf

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Ifenp...

December 5, 2022, 7:57 am

Who will be disney's next ceo? here are the top contenders to succeed bob iger

There are several internal and external candidates who could take over as Disney CEO after Bob Iger end...

December 4, 2022, 8:00 am

What best buy is getting right

Is Zoom a takeover candidate? A Motley Fool look at these topics and other stock market news....

December 3, 2022, 9:59 am

How bitcoin could reach a new all-time high

Bitcoin ( BTC -0.76%) has traditionally been viewed as a hedge against central banks. However, one Harvard Ph.D. ...

December 2, 2022, 12:14 pm

Why shares of prometheus biosciences slumped this week

The company's lead pipeline candidate is facing competition from a Pfizer-backed drug....

December 2, 2022, 11:48 am

Why anavex life sciences stock is surging today

The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate...

December 2, 2022, 11:37 am

Altimmune appears to have a winner, but will the market believe?

On September 14, shares plummeted 27% on topline results from a Phase 1 study of pemvidutide. Reductions in liver fat appear to be substantially bette...

December 2, 2022, 10:19 am

Platinum and the pplt etf- the disappointing metal that remains a candidate for significant appreciation

Platinum has underperformed the precious metals sector for years. Platinum has been consolidating around the $1,000 per ounce level....

December 1, 2022, 3:43 pm

Clover’s vaccine candidate reduced household transmission of sars-cov-2 in study published in clinical infectious diseases

— The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SA...

November 30, 2022, 10:28 am

Biib stock alert: what the latest alzheimer's drug data means for biogen

Biogen (NASDAQ: BIIB ) stock is on the move Wednesday after the company provided the latest update on its Alzheimer's drug ...

November 30, 2022, 10:00 am

Revisiting tracon pharmaceuticals

Today, we look back in on clinical stage developmental firm TRACON Pharmaceuticals for the first time since early 2021. The company's primary drug ...

November 30, 2022, 1:43 am

Pfizer: covid-19 may never end

Pfizer's net income was $8,609 million in Q3 2022, up 5.7% year-on-year. The number of Pfizer product candid...

November 29, 2022, 8:53 pm

Cincor (cinc) tanks due to dismal data on hypertension drug

CinCor (CINC) plummets as its phase II study, HALO, evaluating its lead candidate baxdrostat for hypert...

November 29, 2022, 1:32 pm

Context therapeutics finds lead clinical development candidate for cancer treatment in ctim-76

Context Therapeutics (NASDAQ:CNTX) Inc has designated CTIM-76, a T cell-engaging bispecific antibody, as its lead clinical development ...

November 29, 2022, 10:52 am

Alibaba: candidate for the record book of mispriced stocks

While top line growth is now close to zero, Alibaba could increase operating income, earnings per share, and free cash flow at a high pace. Despite di...

November 29, 2022, 3:54 am

Aquestive therapeutics: going all-in on aqst-109

Aquestive Therapeutics has been making deals to generate cash to help develop their epinephrine candida...

November 29, 2022, 3:18 am


Search within

Pages Search Results: